Solidarity in the European Union would be impacted if nations chose China's Sinovac or Russia's Sputnik V COVID-19 vaccines, French Secretary of State for European affairs Clement Beaune told RTL radio on Friday.
When asked about the outcome of the EU choosing the two vaccines, Beaune said: “I think it would be quite serious".
“It would pose a problem in terms of our solidarity, and it also poses a health risk problem, because the Russian vaccine is not yet authorised in Europe. A demand for approval has been made but it is not yet authorised in Europe, and no demand has even been made yet for the Chinese vaccine,” he added.
The news comes after Slovakia, Hungary and Czech Republic approved or launched approval processes for the Russian and Chinese jabs amid Pfizer-BioNTech and Oxford-AstraZeneca vaccine delays across the bloc.
The European Medical Agency is currently reviewing the Sputnik V vaccine for approval.
The news comes amid a statement from Russia Direct Investment Fund (RDIF) chief executive Kirill Dmitriev, who said Russia could supply its vaccines to 50m EU residents from June after EMA approval, adding the jabs would be tested for compliance with EU efficacy standards.
Mr Dmitriev also added in separate comments numerous European countries had picked Sputnik V amid the EU shortages, stating it could help citizens "feel safe and protected" as well as end the pandemic "as soon as possible".
Several Norwegian municipalities also blasted the shortages across the European bloc, with Pål Gabrielsen telling national radio in early March vaccine rollout delays could have been "avoided" with access to Sputnik V doses.
“This is a situation that should have been avoided by us contacting Russia and pushing for us to have access to the Sputnik V vaccine,” he said at the time.
The news comes after Chinese foreign minister Wang Yi slammed wealthy nations of stockpiling large quantities of COVID-19 vaccines, causing shortages in poorer nations and further politicisation of the ongoing pandemic.
He added that such nations should avoid a "zero sum" game in the fight against COVID-19 and that China did not have geopolitical interest in its vaccine rollout.
To date, 44 countries have approved use of the vaccine, including Laos, Mexico, Armenia, Argentina, Chile, and many others.